Companies similar to PITCH
Sign up to Download

1-30 of 4,526,853 results

  • pitch.yale.edu
  • 1
  • 1
  • 10
PITCH provides a pathway for Yale and UConn researchers to develop new, potentially lifesaving therapeutics based on their discoveries in the lab... By providing a pathway for researchers to find new, potentially life-saving therapeutics based on..
Relevance: 47.93664
  • adorx.com
  • 1
  • 6
AdoRx Therapeutics is a UK-based drug discovery company and backed by investment from Epidarex Capital and the CRT Pioneer Fund managed by Sixth Element Capital... AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer based on..
Relevance: 27.841322
  • www.birchtx.com
  • 6
Birch Therapeutics is a privately held pharmaceutical company focused on developing therapeutics for patients affected by rare diseases. Birch is building a drug development pipeline through the repurposing or reformulation of an approved..
Relevance: 27.225958
  • www.mvtpharma.com
  • 9
Microvascular Therapeutics (MVT) is a biotechnology company specializing in the development of microbubble and nanotechnology products for the diagnosis and treatment of disease... MVT has developed a new, patented formulation, MVT-100, for use as..
Relevance: 27.113174
  • pliantrx.com
  • 4
  • 2
  • 38
Pliant Therapeutics is a clinical-stage biopharmaceutical company leading the way in developing new treatments for fibrotic diseases. As fibrosis is a complex disease, few available treatments for fibrosis exist today. We are committed to advancing..
Relevance: 26.004812
  • coatherapeutics.com
  • 1
  • 5
CoA Therapeutics was founded in 2018 with the aim of developing novel therapies for difficult to treat and rare genetic disorders by harnessing advances in understanding of the CoA pathway... CoA Therapeutics is developing a novel small-molecule..
Relevance: 23.998262
  • www.enleofen.com
  • 1
Enleofen was founded as a spin-out from NHCS, SingHealth and Duke-NUS Medical School focused on developing new anti-fibrotic therapies... Transforming the treatment of fibro-inflammatory diseases Developer of first-in-class therapeutics targeting..
Relevance: 23.974676
  • connexintx.co.uk
  • 1
  • 2
At Connexin Therapeutics, we are developing the options ophthalmologists need to preserve vision in their patients with glaucoma and related conditions... Our goal at Connexin Therapeutics is to develop and partner novel compounds which block..
Relevance: 23.949184
  • www.auctapharma.com
  • 2
  • 4
  • 8
Aucta is a pharmaceutical company creating enhanced products from proven molecules using the 505(b)(2) regulatory pathway. Through innovation, Aucta is creating new therapeutics, including new dosage forms, new dosing regimens, and new indications.....
Relevance: 23.74119
  • groffna.com
  • 1
  • 1
  • 5
Groff North America (Groff NA) is on a mission to help unlock the tremendous potential cannabis-based medicines in the U.S and overseas. Having received authorization from the DEA to grow 100% federally-legal cannabis, we now have a unprecidented..
Relevance: 23.252129
  • www.psychnostics.net
  • 5
PsychNostics is a medical diagnostics and therapeutics company in the business of developing and offering of a new type of blood test for the diagnosis and treatment of mental disorders. This unique, patented technology also offers a related..
Relevance: 23.085833
  • www.pathwaydatabase.org
  • 1
We introduce a new platform for accelerating communication between researchers who are interested in locating pathways with special properties. Pathwaydatabase.org is a web repository of paths and associated metadata that supports a variety of..
Relevance: 22.878077
  • checkpointtx.com
  • 6
  • 5
  • 14
Checkpoint Therapeutics is revolutionizing the way novel treatments for cancer patients are developed. As a fast-follower, our streamlined approach lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more..
Relevance: 22.839832
  • www.decimmunetherapeutics.com
  • 1
  • 5
DecImmune Therapeutics is developing a novel monoclonal antibody, DeciMab™, aimed at preventing tissue damage and preserving organ function in a range of vascular inflammatory diseases... Our approach is based on the discovery of an innate IgM-..
Relevance: 22.757149
  • www.bioxceltherapeutics.com
  • 7
  • 6
  • 25
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. The company's wholly owned, clinical-stage subsidiary, OnkosXcel Therapeutics, is focused on developing..
Relevance: 22.5837
  • www.sirnagen.com
  • 1
  • 3
At siRNAgen Therapeutics, we believe in a future where patients with immunology and CNS conditions can live healthier longer lives. Using a versatile double conjugate micellar RNAi platform called SAMiRNA, siRNAgen is developing an active pipeline of..
Relevance: 22.531809
  • www.abbiotec.com
  • 3
Abbiotec is a different type of reagent company for a new century of demanding and exciting research projects and ideas. Our tools enable the study of human biology and disease at the cellular and molecular levels, with cross applications in..
Relevance: 22.303171
  • e-p-a.org
The European Pathway Association is an international not for profit organisation (ivzw) under Belgian Law of Clinical Pathway/ Care Pathway networks, user groups, academic institutions, supporting organisations and individuals who want to support the..
Relevance: 22.264795
  • kayothera.com
  • 1
  • 1
  • 13
KayoThera specializes in pioneering a novel class of safe oral antagonists that are the first of their kind to target retinoid signaling. Previously considered "undruggable" the retinoid pathway has posed challenges to drug development for nearly..
Relevance: 22.20498
  • www.pictherapeutics.com
  • 1
  • 13
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation... At PIC, our precision-based therapeutics target the..
Relevance: 22.108303
  • drugdiscovery.jhu.edu
  • 16
  • 1
  • 69
JHDD researchers lead a breakthrough study published in Science Advances showing anti-cancer effects of novel compound DRP-104 that is the basis of a current clinical trial... The Johns Hopkins Drug Discovery Program continues to work with the..
Relevance: 22.047344
  • www.theraxyte.com
  • 1
  • 1
TheraXyte BioScience is an innovation-motivated biotechnology company focusing on extracellular vesicle (EV)-mediated drug delivery and EV-based novel therapeutics. The goal of TheraXyte is establishing an EV-based drug delivery platform with..
Relevance: 21.870451
  • www.biozentrum.unibas.ch
  • 4
  • 4
  • 34
Aukera Therapeutics was founded in 2021 by Dr. Stefan Imseng and Dr. Dritan Liko based on an Innosuisse-funded feasibility study. The spin-off from the Biozentrum possesses pioneering expertise to develop new therapies for patients suffering from..
Relevance: 21.691502
  • www.tracttherapeutics.com
  • 1
  • 1
  • 6
TRACT Therapeutics is developing a personalized cellular product with the potential to change the therapeutic approach in transplant medicine by reducing or eliminating the need for immunosuppressive drug therapy... Building on the possibilities of..
Relevance: 21.60653
  • lupustherapeutics.org
  • 15
The Lupus Clinical Investigators Network or LuCIN, developed and overseen by Lupus Therapeutics, is a lupus clinical trials network comprised of the most reputable academic research medical centers throughout North America. LuCIN leverages the..
Relevance: 21.578207
  • agenusbio.com
  • 3
  • 5
  • 18
Agenus is an immuno-oncology company focused on the discovery and development of potentially revolutionary new treatments that leverage the body ™s immune system to fight cancer and infectious diseases... Agenus discovers, manufactures, and develops..
Relevance: 21.531944
  • www.decimmune.com
  • 1
  • 5
Our approach is based on the discovery of an innate IgM-mediated auto-immune pathway that is triggered by vascular injury in conditions such as diabetic nephropathy, renal ischemia, and myocardial infarction. This pathway, dubbed N2, can trigger a..
Relevance: 21.354507
  • mbioscience.com
  • 1
  • 1
Mbioscience Solutions is a biotechnology distribution company that offers next generation sequencing service, immunoassays, antibodies, and pathway analysis tools to support cancer research, food safety testing, immunology, oxidative & cellular..
Relevance: 21.282967
  • stg4fronts.com
  • 1
  • 1
STG 4 Fronts is an organization built out of manufacturers who recognized early on the transformational power of 3D printing, or additive manufacturing, technology. Beyond the ripple effects in the global marketplace which stem from the ability to..
Relevance: 21.188057
  • www.expressiontherapeutics.com
  • 3
  • 1
  • 8
Expression Therapeutics, Inc. is a fully integrated clinical stage gene and cell therapy company developing novel, potentially curative, therapeutics for deadly childhood and adult genetic diseases... The Company's scientific breakthrough in..
Relevance: 21.09515